Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Kelly Lonergan
DHEC Dietetic Intern 2014
Introducing M.B.B.
56 year old
Male
African-American
Admitted 10/14 for this admission
Length of Stay: 29 days so far
MICU
Vent-Dependent, on Tube Feeds
Admissions
Chief Complaints
Diagnoses
Focus: ARDS
(Acute Respiratory Distress Syndrome)
Definition: The inflammation of the lung
parenchyma and increased pulmonary capillary
permeability leading to impaired gas exchange.
Specifically, ARDS is defined as the PaO2 (arterial
partial oxygen tension) to the fraction of FiO2
(inspired oxygen) ratio of below 200 mmHg with
bilateral alveolar infiltrates on the chest x-ray and
a normal pulmonary capillary wedge pressure.
Gehlbach, Hill. 2008. Acute Respiratory Distress Syndrome (ARDS). Merck Manuals.
Focus: ARDS
Essentially, the portion of
the lung involved in gas
exchange is severely
inflamed which causes
pulmonary edema.
Focus: ARDS
This then increases
the distance oxygen
must diffuse to reach
the blood. In general,
the lungs have to
work much harder to
oxygenate the body.
Symptoms
Shortness of breath
Low, rapid breathing
Crackling, wheezing sounds in lungs
Mottled, blue skin d/t lack of oxygen
Possible heart, brain malfunction d/t lack of
oxygen
Arrhythmia, rapid heart rate
Confusion
Lethargy
Diagnosing
Blood sample revealing low levels of oxygen in
the blood
Chest x-ray showing fluid in places where air
should be
White Out
White Out
Treatment
Mechanical ventilation
Nutrition support
Enteral formula enriched with EPA, DHA, and
enhanced levels of antioxidant vitamins
Research
Research
Omega-3 Fatty Acids have many anti-inflammatory
properties
EPA and DHA have beneficial effects on pulmonary
neutrophil recruitment and gas exchange
Can the addition of omega-3 fatty acids in nutrition
improve the disease process of ARDS?
Research
Randomized study had ARDS patients receiving either
a high-lipid enteral formula with EPA or a standard
pulmonary formula.
The testing patients experienced improved oxygenation,
fewer days ventilation, and shorter length of stay in the
ICU
Another study did a similar test with ARDS/sepsis
patients and found the testing group to have a reduced
mortality rate, less days on the vent, and fewer days in
the ICU as well
Raoof, et al. 2010. Severe hypoxemic respiratory failure: part 2--nonventilatory strategies. Chest
Applying Research
Current:
Jevity 1.2 @ 60 ml/hr + 2 packs propass
1788 calories, 92 g protein
High-calorie, high-protein formula
Possible Change:
Pivot 1.5 @ 50 ml/hr
1800 calories, 113 g protein
3.12 g EPA, 1.32 g DHA
Nutritional Implications
Increased calorie needs d/t increased work on
lungs and hypermetabolism
Increased protein requirements to 1.5-2.0 g/kg
BW
Fluid restriction if patient is volume overloaded
Prognosis
Majority of ARDS patients will require
mechanical ventilation and nutrition support
Average length of mechanical ventilation with
ARDS is 10-14 days
MBB on 9 days, with prior intubations
Social Background
Socio-Economics
Socio-economic status unknown
Resides in a nursing home
Also previously at LMC-EC
Family History
No history/genetic relevance available
Family nearly impossible to get into contact with
Family finally responding currently regarding
patients prognosis
Medical Tests
PEG Tube placement by Dr. Richter 2/06/14
Right Above Knee Amputation performed by Dr.
Moore on 9/30/14
Multiple Chest X-Rays
If family chooses aggressive care, patient needs:
PEG placement
Trach
Left Above Knee Amputation
Medications
Laboratory Values
11/09/14
146
109
33
3.6
32
0.86
124
GFR >60
Anthropometrics
Ht: 63 (190.5 cm)
Wt: 66.1 kg (145.5 lbs)
UBW: 198 lb
BMI: 18.2 11/05/14
PES Statement
Inadequate protein-energy intake relating
to decreased ability to consume sufficient
energy, nutrients as evidenced by NPO
status and vent-dependence
Low Sodium
TwoCal HN @ 45 ml/hr
Dysphagia Mechanically Altered w/ NTL and Ensure Plus
Soft, 2g Potassium w/ NTL
Suplena
Mechanically Altered, Low Cholesterol, Low Sodium, w/
Magic Cup
Puree w/ HTL w/ Magic Cup
Jevity 1.2 @ 55ml/hr
Increase to Jevity 1.2 @ 60ml/hr
Jevity 1.2 @ 60ml/hr w/ 2 pkts propass
Maintain/gain weight
No further weight loss
Evaluations
Improving/Resolved
No Change/Declining
Failed bedside swallow
Tolerating TF w/ PEG
study
Drinking some
VFSS w/ penetration on
supplements
thin liquids
Extubated
Lost >19% body weight
Hypernatremia resolving
Weight maintained/gained Aspiration
Intubated x 2
Significant weight loss
Coded
Outcomes of Care
Treatment Avoided
Avoided using an appetite stimulant drug; PO
intake encouraged when on diet
Avoided starting TPN as patients GI system had
great tolerance to Tube Feeding
Contributing RDs
Jennifer Benedetto
Kelly Nyberg
Morgan Robbins
Roxanne Poole
Susan Wilkerson